New Overweight clinical trials: 1,105 posted since Nov 2024

Name: New Overweight clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Overweight clinical trials: 1,105 rows for $55.25, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 68 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/overweight, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

1,105 clinical studies in overweight were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 384 have an industry sponsor and 622 are recruiting or about to. The newest, NCT07926152, was posted on November 9, 2026: Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes (German Diabetes Center).

The request: Every new Overweight clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

1,105New trials
384Industry sponsored
622Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 1,105, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07926152	Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes	German Diabetes Center	Not applicable	Not yet recruiting	Type 2 Diabetes (T2DM), Obesity & Overweight, Sarcopenia	94	Germany	clinicaltrials.gov
November 9, 2026	NCT07925684	Determination of ED90 of Remimazolam Besylate Combined With Alfentanil for Gastroscopy Sedation in Obese Patients	Jianbo Wu	Not applicable	Recruiting	Procedural Sedation and Analgesia, Obesity & Overweight	120	China	clinicaltrials.gov
November 9, 2026	NCT07924761	A Study to Investigate the Effect of Injection Site and Ethnicity on KAI-4729 Pharmacokinetics in Non-Asian and Asian Participants Living...	Kailera	Phase 1	Not yet recruiting	Overweight or Obesity	60	United States	clinicaltrials.gov
November 9, 2026	NCT07924267	A Single Ascending Dose and Multiple Ascending Dose Trial to Assess the Dose, the Efficacy and Oro-sensitivity of Two Modified Linoleic...	EktaH	Phase 1	Completed	Obesity & Overweight, Overweight (BMI > 30)	120	Tunisia	clinicaltrials.gov
November 6, 2026	NCT07923240	Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional...	Research Center of Neurology, Russia	Phase 4	Active not recruiting	Metabolic Abnormalities, Obesity & Overweight, Cerebral Atherosclerosis, Cerebrovascular Disease	30	Russia	clinicaltrials.gov
November 6, 2026	NCT07922798	A Phase I Clinical Trial of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of UBT48128 Tablets in Healthy...	The United Bio-Technology (Hengqin) Co., Ltd.	Phase 1	Not yet recruiting	Overweight , Obesity	60	China	clinicaltrials.gov
November 6, 2026	NCT07922330	A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These...	AstraZeneca	Phase 3	Not yet recruiting	Obesity, Overweight, Type 2 Diabetes Mellitus	330	China, India	clinicaltrials.gov
November 6, 2026	NCT07922005	Lifestyle Interventions and Genetic Scores for Weight Management	National and Kapodistrian University of Athens	Not applicable	Completed	Overweight , Obesity	198	Greece	clinicaltrials.gov
November 6, 2026	NCT07921940	Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy	Medical University of Vienna	Not applicable	Active not recruiting	Obesity & Overweight, Gestational Diabetes Mellitus (GDM), Insulin Resistance, Maternal Obesity Complicating Pregnancy	40	Austria	clinicaltrials.gov
November 6, 2026	NCT07921316	Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous...	Amgen	Phase 1	Not yet recruiting	Obesity, Overweight	356		clinicaltrials.gov
November 5, 2026	NCT07919678	A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)	Pfizer	Phase 3	Recruiting	Obesity, Overweight, Osteoarthritis of the Knee	656	Canada, United States	clinicaltrials.gov
November 5, 2026	NCT07919158	Impact of Dyslipidemia on Metabolic Health of Adults With Overweight/Obesity (IDOM): A Study at the San Raffaele Hospital Center for...	Rovere Querini Patrizia	Observational	Active not recruiting	Dyslipidemia, Obesity & Overweight	900	Italy	clinicaltrials.gov
November 5, 2026	NCT07918846	A Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular Disease	Hoffmann-La Roche	Phase 3	Not yet recruiting	Overweight, Obesity, Cardiovascular Disease	8,200		clinicaltrials.gov
November 5, 2026	NCT07918625	A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without Diabetes	BrightGene Bio-Medical Technology Co., Ltd.	Phase 2	Not yet recruiting	Overweight or Obese Participants Without Diabetes	160	China	clinicaltrials.gov
November 4, 2026	NCT07916194	A Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy Participants	Beijing QL Biopharmaceutical Co.,Ltd	Phase 1	Not yet recruiting	Overweight, Obesity	24	China	clinicaltrials.gov
November 4, 2026	NCT07915609	A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2...	Pfizer	Phase 3	Recruiting	Obesity, Overweight and/or Obesity, Knee Osteoarthritis, Diabetes Melliuts, Type 2	756	United States	clinicaltrials.gov
November 4, 2026	NCT07915245	A Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise Healthy	Eli Lilly and Company	Phase 1	Not yet recruiting	Obesity, Overweight	108	Singapore, United States	clinicaltrials.gov
November 3, 2026	NCT07913685	The Effect of Liraglutide on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight...	Medical University of Bialystok	Phase 4	Completed	Obesity & Overweight	83	Poland	clinicaltrials.gov
November 2, 2026	NCT07911514	A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234	AstraZeneca	Phase 1	Not yet recruiting	Healthy Participants	60	United Kingdom	clinicaltrials.gov
November 2, 2026	NCT07910916	Effects of Concurrent Training on Serum PCSK9 Levels in Adults With Overweight	Kastamonu University	Not applicable	Recruiting	Overweight, Lipid Metabolism, Cholesterol Metabolism	42	Turkey (Türkiye)	clinicaltrials.gov
November 2, 2026	NCT07909772	Effects of a Multispecies Probiotic on Metabolic, Liver, and Gut Health	University of Bari	Not applicable	Completed	Metabolic-Associated Steatotic Liver Disease, Diabetes (DM), Obesity & Overweight	56	Italy	clinicaltrials.gov
November 2, 2026	NCT07909109	An Open Label Pilot Study Assessing the Impact of Chromium Picolinate Supplementation on Appetite and Cravings in Overweight Individuals	Nutrition 21, Inc.	Observational	Recruiting	Overweight (BMI > 25), Appetite, Craving	138	United States	clinicaltrials.gov
November 2, 2026	NCT07908823	ERCG vs Intensive Lifestyle Intervention for Weight Regain After GLP-1 RA Discontinuation	Affiliated Hospital to Academy of Military Medical Sciences	Not applicable	Not yet recruiting	Obesity & Overweight	60	China	clinicaltrials.gov
November 2, 2026	NCT07908316	Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After...	Amgen	Phase 1	Recruiting	Obesity, Overweight	180	United States	clinicaltrials.gov
October 30, 2026	NCT07907029	Transcutaneous Auricular Vagus Nerve Stimulation Combined With Lifestyle Intervention for Visceral Fat Reduction in Adults With Overweight...	Guangdong Provincial Hospital of Traditional Chinese Medicine	Not applicable	Not yet recruiting	Overweight, Obesity	50	China	clinicaltrials.gov
October 29, 2026	NCT07902752	Oxytocin for Respiratory Compromise and Hypoventilation Induced by Drugs	George Washington University	Phase 2	Not yet recruiting	Obesity & Overweight, Respiratory Depression, Intranasal Drug Administration, Oxytocin, Bariatric Surgery	100		clinicaltrials.gov
October 28, 2026	NCT07901777	Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With Obesity	Yuzuncu Yil University	Observational	Recruiting	Obesity & Overweight	200	Turkey (Türkiye)	clinicaltrials.gov
October 28, 2026	NCT07900633	A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk	Eli Lilly and Company	Phase 3	Not yet recruiting	Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2	3,000	Argentina, Australia, Brazil, Canada, China, Czechia, France, Germany, Hungary...	clinicaltrials.gov
October 28, 2026	NCT07900178	Sustaining Health After an Intensive Weight-loss Pro-gramme	Copenhagen University Hospital, Hvidovre	Observational	Enrolling by invitation	Obesity & Overweight, Weight Loss, Weight Management in Adult Patients With Obesity or Overweight	150	Denmark	clinicaltrials.gov
October 27, 2026	NCT07898267	Gut Microbiota-Based Clinical Study of Akkermansia Supplementation for Overweight and Obesity	Second Affiliated Hospital of Nanchang University	Not applicable	Not yet recruiting	Obesity & Overweight	150	China	clinicaltrials.gov
October 27, 2026	NCT07897890	Testing Health-Related Interventions: Voices of Equity Needed to Overcome Weight-bias in Obesity-Cancer Care	Indiana University	Not applicable	Completed	Obesity & Overweight, Breast Cancer	12	United States	clinicaltrials.gov
October 27, 2026	NCT07897682	Impact of Significant Surgical Reduction of Adipose Tissue on Plasma Levels and Genetic Expression of Adipokines Associated With Ischemic...	King Edward Medical University	Not applicable	Not yet recruiting	Obesity & Overweight, Obesity Type I and II	212	Pakistan	clinicaltrials.gov
October 27, 2026	NCT07897383	Investigating the Effects of 24 Hour LEAP2 Infusion in Individuals With Overweight and Obesity	University Hospital, Gentofte, Copenhagen	Phase 1/2	Not yet recruiting	Obesity & Overweight	18		clinicaltrials.gov
October 27, 2026	NCT07897305	Mazdutide for Reducing Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients	Beijing Anzhen Hospital	Not applicable	Not yet recruiting	Atrial Fibrillation (AF), Ablation Treatment, Obesity & Overweight, Mazdutide	700	China	clinicaltrials.gov
October 26, 2026	NCT07896265	Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes	Regeneron Pharmaceuticals	Phase 3	Not yet recruiting	Overweight or Obesity Without Diabetes	3,000		clinicaltrials.gov
October 26, 2026	NCT07895563	A Study to Evaluate the Effects of a Dietary Supplement on Weight Management and Appetite Control	MNnutra	Not applicable	Active not recruiting	Overweight, Obesity, Weight Management, Appetite Control	170	United States	clinicaltrials.gov
October 26, 2026	NCT07893743	Changes in Intestinal Permeability and Systemic Inflammation Following Fast Food Overfeeding.	University Hospital, Gentofte, Copenhagen	Not applicable	Recruiting	Obesity & Overweight	20	Denmark	clinicaltrials.gov
October 26, 2026	NCT07893717	Motivational Interviewing Intervention for Families With Overweight and Obesity	Universidad Autonoma de Baja California	Not applicable	Active not recruiting	Obesity & Overweight	120	Mexico	clinicaltrials.gov
October 23, 2026	NCT07893249	Individual Variability in Energy Compensation After a 12-Week Supervised Exercise Intervention	Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences	Not applicable	Not yet recruiting	Physical Inactivity, Overweight, Obesity	150	China	clinicaltrials.gov
October 23, 2026	NCT07891156	Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.	McGill University Health Centre/Research Institute of the McGill University Health Centre	Phase 2/3	Recruiting	Type 1 Diabetes, Overweight , Obesity	40	Canada	clinicaltrials.gov
October 22, 2026	NCT07890870	A Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity.	iBio, Inc.	Phase 1	Not yet recruiting	Obesity & Overweight	32	Australia	clinicaltrials.gov
October 22, 2026	NCT07890376	A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes	Eli Lilly and Company	Phase 2	Not yet recruiting	Obesity, Overweight	460	Argentina, United States	clinicaltrials.gov
October 22, 2026	NCT07889570	A Controlled Study to Evaluate the Effects of a Supplement on Weight Loss, Blood Sugar, and Appetite Suppression	Evolv	Not applicable	Completed	Overweight, Obesity, Blood Sugar Regulation, Appetite Suppression, Weight Management	98	United States	clinicaltrials.gov
October 21, 2026	NCT07886788	Study of Grape Consumption in Adaptation to Seasonal Photoperiod	University Rovira i Virgili	Not applicable	Active not recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease, Overweight, Obesity & Overweight	46	Spain	clinicaltrials.gov
October 21, 2026	NCT07884903	Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks	Shanxi Bethune Hospital	Observational	Not yet recruiting	Obesity & Overweight, Diabetes Mellitus, Type 2, Hypertension, Non-alcoholic Fatty Liver Disease (MASLD)...	25,974	China	clinicaltrials.gov
October 20, 2026	NCT07884058	IGOB131 As A GLP-1 Modulator For Metabolic Disorders In Adults With Obesity	University of Yaounde 1	Phase 2	Not yet recruiting	Obesity & Overweight	80		clinicaltrials.gov
October 20, 2026	NCT07883031	Effects of Yerba Mate Supplementation on Metabolic Health, Physical Function, and Cognition in Older Adults With Excess Adiposity	University of North Alabama	Not applicable	Completed	Overweight (BMI > 25), Obesity & Overweight	25	United States	clinicaltrials.gov
October 20, 2026	NCT07882654	A PHASE 2A, EXPLORATORY, RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY OF WEIGHT LOSS INDUCED BY NKS-3 IN...	EktaH	Phase 2	Not yet recruiting	Obesity / Overweight, Obesity (BMI Equal to or >30)	31	Tunisia	clinicaltrials.gov
October 20, 2026	NCT07881887	A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes	Eli Lilly and Company	Phase 1	Not yet recruiting	Obesity, Overweight, Diabetes Mellitus, Type 2	617	Singapore, United States	clinicaltrials.gov
October 19, 2026	NCT07881770	Semaglutide Health Outcomes and Patient Adherence in Australia	Novo Nordisk A/S	Observational	Not yet recruiting	Overweight, Obesity	10,000	Australia	clinicaltrials.gov
October 19, 2026	NCT07881458	A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes	Eli Lilly and Company	Phase 3	Recruiting	Obesity, Overweight, Diabetes Mellitus, Type 2	1,000	Brazil, China, Germany, Japan, Puerto Rico, Romania, South Korea, Spain...	clinicaltrials.gov
October 19, 2026	NCT07880717	Prevalence and Associated Factors of High BMI and Periodontitis in Thai Adults Aged Under 60 Years	Mahidol University	Observational	Recruiting	Diabete Mellitus, Dyslipidaemia, Chronic Kidney Disease, Psychiatric Disorder, Hypertension, Hypothyroidism, Smoking...	93	Thailand	clinicaltrials.gov
October 15, 2026	NCT07877038	Pharmacokinetics, Safety, and Tolerability of DA-302168S Tablets in Participants With Hepatic Impairment and Normal Hepatic Function	Chendu DIAO Pharmaceutical Group CO., LTD.	Phase 1	Not yet recruiting	Obesity, Overweight, T2DM (Type 2 Diabetes Mellitus)	32		clinicaltrials.gov
October 15, 2026	NCT07876531	A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or...	Pfizer	Phase 1	Recruiting	Overweight and/or Obesity, Healthy Participants	144	United States	clinicaltrials.gov
October 15, 2026	NCT07876518	A Study to Learn How Different Amounts of the Study Medicine Called PF-08656795 Are Tolerated and Act in Adults With Overweight or Obesity	Pfizer	Phase 1	Not yet recruiting	Overweight and/or Obesity	150		clinicaltrials.gov
October 15, 2026	NCT07874828	PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A...	M.D. Anderson Cancer Center	Phase 2	Recruiting	Sarcoma,Soft Tissue	30	United States	clinicaltrials.gov
October 15, 2026	NCT07874633	A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or...	Pfizer	Phase 3	Recruiting	Obesity, Overweight	432	China	clinicaltrials.gov
October 14, 2026	NCT07873762	Effects of a 12-Week Individualized Energy-Restricted Diet on Perceived Stress and Serum Cortisol in Adults With Overweight or Obesity	Acibadem University	Not applicable	Completed	Obesity & Overweight	30	Turkey (Türkiye)	clinicaltrials.gov
October 14, 2026	NCT07873645	Study of UBT37034 Injection	The United Bio-Technology (Hengqin) Co., Ltd.	Phase 1	Recruiting	Overweight , Obesity	40	China	clinicaltrials.gov
October 14, 2026	NCT07872904	FutureShape Family	Signe Torekov	Phase 4	Recruiting	Obesity, Overweight	400	Denmark	clinicaltrials.gov
October 13, 2026	NCT07871565	Time-Restricted Eating With or Without Energy Restriction in Dyslipidemic Women With Owerweight or Obesity	Acibadem University	Not applicable	Completed	Dyslipidemia, Obesity & Overweight	56	Turkey (Türkiye)	clinicaltrials.gov
October 13, 2026	NCT07871409	Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight	Amgen	Phase 3	Recruiting	Obesity, Overweight	230	Puerto Rico, United States	clinicaltrials.gov
October 13, 2026	NCT07870668	Intermittent Phentermine for Obesity and Body Composition	OSCAR MANUEL TORRES FALCON	Phase 4	Completed	Obesity & Overweight	600	Mexico	clinicaltrials.gov
October 13, 2026	NCT07870538	A Neuropsychobiological Approach to Optimize Patient Selection for GLP-1-based Pharmacotherapy for Weight Management Across the Binge...	Universitaire Ziekenhuizen KU Leuven	Phase 4	Recruiting	Obesity & Overweight	96	Belgium	clinicaltrials.gov
October 13, 2026	NCT07869758	Gastric On in Obesity Management: Evaluation of the Safety and Efficacy of the 6-Month Gastric Balloon (Prospective)	Rigicon, Inc.	Not applicable	Completed	Obesity & Overweight	42	Turkey (Türkiye)	clinicaltrials.gov
October 9, 2026	NCT07868354	A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New...	Novo Nordisk A/S	Phase 1	Recruiting	Overweight, Obesity, Type 2 Diabetes	60	United States	clinicaltrials.gov
October 8, 2026	NCT07866066	Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes	Amgen	Phase 3	Recruiting	Diabetes Mellitus, Type 2	1,300	Canada, United States	clinicaltrials.gov
October 6, 2026	NCT07861529	Effects of Posterior Gastropexy During Sleeve Gastrectomy on Quality of Life	Helwan University	Not applicable	Completed	Obesity & Overweight	50	Egypt	clinicaltrials.gov
October 6, 2026	NCT07861048	Active Versus Passive Recovery During HIIT in Children With Overweight or Obesity	High Institute of Sports and Physical Education of Kef	Not applicable	Completed	Overweight and Obesity	30	Tunisia	clinicaltrials.gov
October 5, 2026	NCT07859072	WB-EMS Combined With Nutritional Guidance for a High-Protein Diet on Body Composition, Muscle Function, Psychological and Functional...	Universidade Cesumar (UNICESUMAR)	Not applicable	Not yet recruiting	Overweight (BMI > 25), Obesity & Overweight, Aging	36	Brazil	clinicaltrials.gov
October 5, 2026	NCT07857473	A Study to Investigate the Safety and Efficacy of TE-8105 in Overweight or Obesity Participants	Immunwork, Inc.	Phase 2	Not yet recruiting	Overweight and Obesity	204	Australia	clinicaltrials.gov
October 5, 2026	NCT07857018	Long-term Follow-up After Childhood Obesity	Ulla Toft	Observational	Not yet recruiting	Overweight , Obesity	6,100		clinicaltrials.gov
October 5, 2026	NCT07856784	Cognitive and Behavioral Approaches to Reduce Binge Eating and Excess Weight in Adolescents (Online)	Indiana University	Not applicable	Not yet recruiting	Binge Eating, Overweight and Obesity, Eating Disorders in Adolescence	159	United States	clinicaltrials.gov
October 2, 2026	NCT07855939	Long-term Iron Absorption and Loss in Women	Mahidol University	Observational	Recruiting	Obesity & Overweight, Normal Weight Adults	64	Thailand	clinicaltrials.gov
October 2, 2026	NCT07855133	A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New...	Novo Nordisk A/S	Phase 1	Recruiting	Overweight, Obesity, Type 2 Diabetes	60	United States	clinicaltrials.gov
October 2, 2026	NCT07853898	Effects of Pistachios on Postprandial Metabolic Responses in Adults With Overweight or Obesity	St. Louis University	Not applicable	Recruiting	Obesity / Overweight	28	United States	clinicaltrials.gov
October 1, 2026	NCT07850960	Effect of Omeprazole on Gut Microbiota in Adults With Obesity and GERD	Federal State Budgetary Scientific Institution	Phase 4	Not yet recruiting	Obesity & Overweight, Gastroesophageal Reflux Disease	26	Russia	clinicaltrials.gov
September 30, 2026	NCT07850765	Real-World Patient and Physician Experience With Semaglutide Across Six Emerging Markets	Novo Nordisk A/S	Observational	Completed	Overweight, Obesity	1,260	Israel, Mexico, Saudi Arabia, South Africa, Turkey (Türkiye), United Arab...	clinicaltrials.gov
September 30, 2026	NCT07850531	Precision Nutrition for Obesity and Prediabetes Prevention in Under-supported Communities	Prairie View A&M University	Not applicable	Not yet recruiting	Obesity & Overweight, Prediabetes	100	United States	clinicaltrials.gov
September 30, 2026	NCT07850466	TRPTI Metabolic and GLP-1 Pharmacodynamic Study	RDC Clinical Pty Ltd	Phase 4	Not yet recruiting	Overweight , Obesity	20	Australia	clinicaltrials.gov
September 30, 2026	NCT07849439	Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study	St. Louis University	Not applicable	Recruiting	Overweight , Obesity	12	United States	clinicaltrials.gov
September 29, 2026	NCT07847515	Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients	Nanjing First Hospital, Nanjing Medical University	Observational	Not yet recruiting	Obesity / Overweight	80	China	clinicaltrials.gov
September 29, 2026	NCT07847307	ENDOBARIHEART STUDY	Maria Cecilia Hospital	Not applicable	Not yet recruiting	Obesity & Overweight	50	Italy	clinicaltrials.gov
September 29, 2026	NCT07846865	Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea	Woolcock Institute of Medical Research	Phase 2/3	Not yet recruiting	Sleep Apnoea, Obesity & Overweight, Sleep Apnea Syndrome, Obstructive	256	Australia	clinicaltrials.gov
September 29, 2026	NCT07845773	Effects of Antenatal Nutrition Counseling on Maternal and Infant Outcomes	Eastern Mediterranean University	Not applicable	Completed	Overweight, Pregnancy	108	Cyprus	clinicaltrials.gov
September 29, 2026	NCT07845578	A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight	Novo Nordisk A/S	Phase 1	Not yet recruiting	Obesity, Overweight	60	Austria	clinicaltrials.gov
September 29, 2026	NCT07845513	A Study to Learn About the Study Medicine Called PF-08653944 in Otherwise Healthy Chinese Adults With Overweight or Obesity	Pfizer	Phase 1	Active not recruiting	Overweight, Obesity, Healthy Adults	11	China	clinicaltrials.gov
September 29, 2026	NCT07845500	A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With...	Pfizer	Phase 3	Recruiting	Obesity, Overweight and/or Obesity, Overweight, Treatment Of Obesity	660	Australia, United States	clinicaltrials.gov
September 28, 2026	NCT07844512	Safety and Analgesic Efficacy of the Biased μ-Opioid Receptor Agonist Tegileridine for Post-Operative Analgesia in Patients Undergoing...	The First Hospital of Jilin University	Phase 3	Recruiting	Pain Management, Overweight , Obesity, Respiration; Sleep Disorder	148	China	clinicaltrials.gov
September 28, 2026	NCT07843498	A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity	Hoffmann-La Roche	Phase 3	Recruiting	Obesity or Overweight	3,900	United States	clinicaltrials.gov
September 28, 2026	NCT07843485	A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes	Hoffmann-La Roche	Phase 3	Recruiting	Obesity or Overweight, Type 2 Diabetes	600	United States	clinicaltrials.gov
September 28, 2026	NCT07843472	A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established...	Hoffmann-La Roche	Phase 3	Recruiting	Obesity or Overweight, Cardiovascular Disease	2,500	United States	clinicaltrials.gov
September 25, 2026	NCT07843082	Exercise and Tissue-Specific Insulin Sensitivity in South Asian and Nordic Women With Previous Gestational Diabetes	Oslo University Hospital	Not applicable	Completed	Diabetes, Obesity & Overweight	43	Norway	clinicaltrials.gov
September 25, 2026	NCT07840846	Standardized Large Yellow Tea Extract for Glucose and Lipid Metabolism in Overweight Adults With Hypertriglyceridemia	The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)	Not applicable	Not yet recruiting	Hypertriglyceridemia, Overweight , Obesity	138		clinicaltrials.gov
September 25, 2026	NCT07840807	Traditional Chinese Medicine Fasting Therapy, Ketone Levels, and Metabolic Improvements	The Seventh Affiliated Hospital of Sun Yat-sen University	Observational	Completed	Obesity & Overweight, Diabete Type 2, Metabolic Syndrome	1,149	China	clinicaltrials.gov
September 25, 2026	NCT07840274	Effects of Daily Kefir Consumption During Medical Nutrition Therapy on Body Composition and Psychological Well-Being in Women With Obesity	Pınar Göbel	Not applicable	Completed	Obesity & Overweight, Gut Microbiota, Body Composition	68	Turkey (Türkiye)	clinicaltrials.gov
September 24, 2026	NCT07840170	Whole Food Fibers for Support of Key Gut Bacteria for Human Health	Purdue University	Not applicable	Not yet recruiting	Prediabetes or Overweight	24	United States	clinicaltrials.gov
September 24, 2026	NCT07837973	Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss	Alveus Therapeutics, Inc.	Phase 2	Recruiting	Overweight , Obesity, Adults	220	United States	clinicaltrials.gov
September 23, 2026	NCT07836582	Physical Activity for Depressive Symptoms in Adults With Obesity: A Randomized Controlled Feasibility Trial	Universite du Quebec en Outaouais	Not applicable	Not yet recruiting	Obesity & Overweight, Depression Disorders	26	Canada	clinicaltrials.gov
September 23, 2026	NCT07836322	SHIFT-TB: Nutrition Intervention and Evaluation	National University of Singapore	Not applicable	Recruiting	Underweight, Overweight and Obesity	700	Cambodia	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Eli Lilly and Company	49	November 4, 2026
Novo Nordisk A/S	48	October 19, 2026
Amgen	23	November 6, 2026
Pfizer	23	November 5, 2026
Hoffmann-La Roche	13	November 5, 2026
Shanghai Minwei Biotechnology Co., Ltd	13	September 4, 2026
AstraZeneca	10	November 6, 2026
BrightGene Bio-Medical Technology Co., Ltd.	8	November 5, 2026
Beijing QL Biopharmaceutical Co.,Ltd	8	November 4, 2026
Kailera	7	November 9, 2026
University of Alabama at Birmingham	7	September 18, 2026
Fujian Shengdi Pharmaceutical Co., Ltd.	7	September 8, 2026
The United Bio-Technology (Hengqin) Co., Ltd.	6	November 6, 2026
Vincentage Pharma Co., Ltd	6	January 16, 2026
Gan & Lee Pharmaceuticals.	6	December 18, 2025
University Hospital, Gentofte, Copenhagen	5	October 27, 2026
Regeneron Pharmaceuticals	5	October 26, 2026
Innovent Biologics (Suzhou) Co. Ltd.	5	September 9, 2026
Pamukkale University	5	August 4, 2026
Johns Hopkins University	5	June 23, 2026

By phase

Phase	New trials	Latest
Not applicable	529	November 9, 2026
Observational	166	November 5, 2026
Phase 1	155	November 9, 2026
Phase 3	99	November 6, 2026
Phase 2	92	November 5, 2026
Phase 4	40	November 6, 2026
Phase 1/2	10	October 27, 2026
Early phase 1	10	September 22, 2026
Phase 2/3	4	October 23, 2026

By country

Country	New trials	Latest
United States	348	November 9, 2026
China	187	November 9, 2026
Turkey (Türkiye)	79	November 2, 2026
Spain	65	October 28, 2026
Canada	61	November 5, 2026
Germany	60	November 9, 2026
United Kingdom	53	November 2, 2026
Australia	48	October 28, 2026
Poland	47	November 3, 2026
Italy	42	November 5, 2026
Japan	34	October 28, 2026
Argentina	32	October 28, 2026
France	32	October 28, 2026
Denmark	31	October 28, 2026
Taiwan	31	October 19, 2026
Mexico	30	October 28, 2026
Brazil	29	October 28, 2026
Czechia	29	October 28, 2026
Puerto Rico	28	October 28, 2026
South Korea	25	October 28, 2026
India	22	November 6, 2026
Netherlands	22	August 18, 2026
Greece	20	November 6, 2026
Singapore	19	November 4, 2026
Belgium	19	October 13, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.